Advertisement

Topics

Tetraphase Pharmaceuticals Inc. Company Profile

14:51 EST 6th December 2016 | BioPortfolio

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs such as the treatment of serious drug-resistant and gram-negative infections. The company has developed an emerging pipeline of potent novel antibiotics that provide a portfolio of intravenous and oral drug candidates with the potential to treat a wide range of infections, including broad-spectrum and selective-spectrum infections. To learn more about Tetraphase, please visit www.tphase.com.


News Articles [1419 Associated News Articles listed on BioPortfolio]

BRIEF-Tetraphase Pharmaceuticals reports Q2 loss per share $0.47

* Tetraphase pharmaceuticals reports second quarter 2016 financial results and highlights recent progress

BRIEF-Tetraphase says publishes phase 3 IGNITE1 eravacycline data in JAMA surgery

* Tetraphase pharmaceuticals inc - in trial, eravacycline was well tolerated

BRIEF-Tetraphase Pharmaceuticals files for mixed shelf

* Tetraphase Pharmaceuticals Inc files for mixed shelf of up to $100 million - SEC filing Source text - (http://bit.ly/2fwQ4M0) Further company coverage:

Larry Tsai of Tetraphase Pharmaceuticals: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Dr. Larry W. Tsai has been Vice President of Clinical Development of Tetraphase Pharmaceuticals since 2015. In this role he establishes clinical development plans and ... The post Larry Tsai of Tetrap...

Tetraphase Pharmaceuticals begins dosing of first patient in IGNITE4 trial of eravacycline to treat cIAI

Tetraphase Pharmaceuticals has announced the dosing of its first patient in IGNITE4, the phase 3 clinical study analysing the efficacy and safety of intravenous (IV) eravacycline compared to meropenem...

Tetraphase Pharmaceuticals starts phase 1 clinical trial for TP-6076

Tetraphase Pharmaceuticals has started patient dosing in a phase 1 clinical trial for intravenous (IV) TP-6076, a novel antibiotic candidate being developed for the treatment of serious and life-threa...

Tetraphase doses first patient in phase 3 trial of Eravacycline in cIAI

Tetraphase Pharmaceuticals has dosed the first patient in IGNITE4, it's phase 3 clinical trial evaluating the efficacy and safety of intravenous (IV) eravacycline compared to meropenem in complicated ...

Tetraphase Pharmaceuticals Added to the Russell Microcap® Index

WATERTOWN, Mass., June 28, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threateni...

Drugs and Medications [0 Results]

None

PubMed Articles [147 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Photosynthetic sensitivity of phytoplankton to commonly used pharmaceuticals and its dependence on cellular phosphorus status.

Recently pharmaceuticals have become significant environmental pollutants in aquatic ecosystems, that could affect primary producers such as microalgae. Here we analyzed the effect of pharmaceuticals ...

Occurrence of pharmaceuticals and cocaine in a Brazilian coastal zone.

The present study determined environmental concentrations of pharmaceuticals, cocaine, and the main human metabolite of cocaine in seawater sampled from a subtropical coastal zone (Santos, Brazil). Th...

Fate of pharmaceuticals and pesticides in fly larvae composting.

A novel and efficient organic waste management strategy currently gaining great attention is fly larvae composting. High resource recovery efficiency can be achieved in this closed-looped system, but ...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 300 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 300 mg (Apsen Pharmaceuticals A / S.), after single dose oral administration to healthy subjects of both sexes, ...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 200 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 200 mg (Apsen Pharmaceuticals A / S.) after single dose oral administration to healthy subjects of both sexes, u...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Fluoxetine Tablets 20 mg and Sarafem® 20 mg Tablets of Warner Chilcott LLC, USA. Dosing periods of studies were separated ...

Companies [3 Associated Companies listed on BioPortfolio]

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-gen...

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the gl...

Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation...

More Information about "Tetraphase Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Tetraphase Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Tetraphase Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Tetraphase Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tetraphase Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Tetraphase Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record